BioSpace News Archive

NewAmsterdam Pharma Company N.V. announced financial results for the fourth quarter and full year ended December 31, 2023 and provided a corporate update.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced the completion of the clinical stage of its Phase 1, single ascending dose escalation trial of TNX-1500 (Fc-modified humanized anti-CD40L monoclonal antibody, or mAb)* in healthy volunteers.

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, March 5, 2024, at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and year end 2023 and to highlight recent corporate progress.

Genetic Technologies Limited, is pleased to announce the launch of a wide-reaching customer – targeted digital advertising campaign in the United States.

Applied Therapeutics, Inc. today announced that it has entered into a securities purchase agreement for a private placement of $100 million of equity.

A pre-clinical study just released in Advances in Bioscience and Biotechnology demonstrates impressive benefits to skin structure from using Lycored’s Lumenato® combined with ceramides.

Edgewise Therapeutics, Inc. today announced that the company will present data on EDG-5506, an investigational therapy designed to protect injury-susceptible fast skeletal muscle fibers in dystrophinopathies, at the Muscular Dystrophy Association Clinical and Scientific Conference.

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Company will participate in fireside chats at two upcoming investor conferences.

Umoja Biopharma, Inc., (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR T cell therapies in oncology and autoimmunity, today announced the appointment of Britton Russell as Chief Financial Officer.

Electromed, Inc. today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the 2024 Sidoti March Small-Cap Virtual Conference on March 13-14, 2024.